Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Cohort profile: The Canadian Longitudinal Study on Aging (CLSA).

Raina P, Wolfson C, Kirkland S, Griffith LE, Balion C, Cossette B, Dionne I, Hofer S, Hogan D, van den Heuvel ER, Liu-Ambrose T, Menec V, Mugford G, Patterson C, Payette H, Richards B, Shannon H, Sheets D, Taler V, Thompson M, Tuokko H, Wister A, Wu C, Young L.

Int J Epidemiol. 2019 Oct 11. pii: dyz221. doi: 10.1093/ije/dyz221. [Epub ahead of print] No abstract available.

PMID:
31605135
2.

Proceedings of the Canadian Frailty Network Workshop: Identifying Biomarkers of Frailty to Support Frailty Risk Assessment, Diagnosis and Prognosis. Toronto, January 15, 2018.

Muscedere J, Kim PM, Afilalo J, Balion C, Baracos VE, Bowdish D, Cesari M, Erusalimsky JD, Fülöp T, Heckman G, Howlett SE, Khadaroo RG, Kirkland JL, Rodriguez Mañas L, Marzetti E, Paré G, Raina P, Rockwood K, Sinclair A, Skappak C, Verschoor C, Walter S.

J Frailty Aging. 2019;8(3):106-116. doi: 10.14283/jfa.2019.12.

PMID:
31237310
3.

Corrigendum to "Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadian" [Toxicol. Lett. 312 (2019) 148-156].

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Oct 1;313:207. doi: 10.1016/j.toxlet.2019.05.022. Epub 2019 Jun 8. No abstract available.

PMID:
31182248
4.

WITHDRAWN: Corrigendum to "Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadian" [Toxicol. Lett. 312 (2019) 148-156].

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Jun 1. pii: S0378-4274(19)30159-6. doi: 10.1016/j.toxlet.2019.05.020. [Epub ahead of print]

PMID:
31163208
5.

Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadians.

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Sep 15;312:148-156. doi: 10.1016/j.toxlet.2019.05.014. Epub 2019 May 14. Erratum in: Toxicol Lett. 2019 Jun 8;:.

PMID:
31100493
6.

Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group.

Booth RA, McCudden CR, Balion CM, Blasutig IM, Bouhtiauy I, Rodriguez-Capote K, Catomeris P, Chan PC, Chen Y, Collier C, Hauff K, Kalra J, Li D, Lin DC, Lou AH, Meng QH, Morrison T, Pasic MD, Qureshi M, Randell E, Sohn KY, Thakur V, Thomas D, Thoni A, Tomalty C, Yang L, Zamkanei M.

Clin Biochem. 2018 Jan;51:10-20. doi: 10.1016/j.clinbiochem.2017.10.013. Epub 2017 Oct 20.

7.

National Survey of Adult and Pediatric Reference Intervals in Clinical Laboratories across Canada: A Report of the CSCC Working Group on Reference Interval Harmonization.

Adeli K, Higgins V, Seccombe D, Collier CP, Balion CM, Cembrowski G, Venner AA, Shaw J; CSCC Reference Interval Harmonization (hRI) Working Group.

Clin Biochem. 2017 Nov;50(16-17):925-935. doi: 10.1016/j.clinbiochem.2017.06.006. Epub 2017 Jun 21.

PMID:
28647526
8.

The relation between DNA methylation patterns and serum cytokine levels in community-dwelling adults: a preliminary study.

Verschoor CP, McEwen LM, Kohli V, Wolfson C, Bowdish DM, Raina P, Kobor MS, Balion C.

BMC Genet. 2017 Jun 21;18(1):57. doi: 10.1186/s12863-017-0525-3.

9.

A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood.

Verschoor CP, Kohli V, Balion C.

Cytometry B Clin Cytom. 2018 Sep;94(5):662-670. doi: 10.1002/cyto.b.21526. Epub 2017 May 22.

10.

Statistical methods used in the calculation of geriatric reference intervals: a systematic review.

Arseneau E, Balion CM.

Clin Chem Lab Med. 2016 Mar;54(3):377-88. doi: 10.1515/cclm-2015-0420. Review.

11.

Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review.

Don-Wauchope AC, Santaguida PL, Oremus M, McKelvie R, Ali U, Brown JA, Bustamam A, Sohel N, Hill SA, Booth RA, Balion C, Raina P.

Heart Fail Rev. 2014 Aug;19(4):521-40. doi: 10.1007/s10741-014-9443-x. Review.

PMID:
25120174
12.

B-type natriuretic peptide-guided therapy: a systematic review.

Balion C, McKelvie R, Don-Wauchope AC, Santaguida PL, Oremus M, Keshavarz H, Hill SA, Booth RA, Ali U, Brown JA, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):553-64. doi: 10.1007/s10741-014-9451-x. Review.

PMID:
25074674
13.

BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.

Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, Balion C, Booth RA, Brown JA, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):453-70. doi: 10.1007/s10741-014-9442-y. Review.

PMID:
25062653
14.

Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review.

Don-Wauchope AC, Santaguida PL, McKelvie R, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, Hill SA, Booth RA, Balion C, Raina P.

Heart Fail Rev. 2014 Aug;19(4):541-51. doi: 10.1007/s10741-014-9446-7.

PMID:
25052419
15.

Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review.

Santaguida PL, Don-Wauchope AC, Ali U, Oremus M, Brown JA, Bustamam A, Hill SA, Booth RA, Sohel N, McKelvie R, Balion C, Raina P.

Heart Fail Rev. 2014 Aug;19(4):507-19. doi: 10.1007/s10741-014-9444-9. Review.

PMID:
25052418
16.

Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.

Narula N, Ulic D, Al-Dabbagh R, Ibrahim A, Mansour M, Balion C, Marshall JK.

Can J Gastroenterol Hepatol. 2014 Sep;28(8):421-6. Epub 2014 Jul 11.

17.

BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Oremus M, Don-Wauchope A, McKelvie R, Santaguida PL, Hill S, Balion C, Booth R, Brown JA, Ali U, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):471-505. doi: 10.1007/s10741-014-9439-6. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24986335
18.

Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Booth RA, Hill SA, Don-Wauchope A, Santaguida PL, Oremus M, McKelvie R, Balion C, Brown JA, Ali U, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):439-51. doi: 10.1007/s10741-014-9445-8. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24969534
19.

Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence.

Hill SA, Booth RA, Santaguida PL, Don-Wauchope A, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Balion C, Raina P.

Heart Fail Rev. 2014 Aug;19(4):421-38. doi: 10.1007/s10741-014-9447-6. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24957908
20.

A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.

Oremus M, McKelvie R, Don-Wauchope A, Santaguida PL, Ali U, Balion C, Hill S, Booth R, Brown JA, Bustamam A, Sohel N, Raina P.

Heart Fail Rev. 2014 Aug;19(4):413-9. doi: 10.1007/s10741-014-9440-0. Review. Erratum in: Heart Fail Rev. 2014 Aug;19(4):565.

PMID:
24953975
21.

Use of Natriuretic Peptide Measurement in the Management of Heart Failure [Internet].

Balion C, Don-Wauchope A, Hill S, Santaguida PL, Booth R, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Raina P.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

22.

Validating chronic disease ascertainment algorithms for use in the Canadian longitudinal study on aging.

Oremus M, Postuma R, Griffith L, Balion C, Wolfson C, Kirkland S, Patterson C, Shannon HS; CLSA Algorithms Validation Group, Raina P.

Can J Aging. 2013 Sep;32(3):232-9. doi: 10.1017/S0714980813000275. Epub 2013 Aug 8.

PMID:
23924995
23.

Hematocrit correction does not improve glucose monitor accuracy in the assessment of neonatal hypoglycemia.

Wang L, Sievenpiper JL, de Souza RJ, Thomaz M, Blatz S, Grey V, Fusch C, Balion C.

Clin Chem Lab Med. 2013 Aug;51(8):1627-35. doi: 10.1515/cclm-2012-0436.

PMID:
23420286
24.

Vitamin D, cognition, and dementia: a systematic review and meta-analysis.

Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P.

Neurology. 2012 Sep 25;79(13):1397-405. Review.

25.

Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard”.

Trikalinos TA, Balion CM.

In: Chang SM, Matchar DB, Smetana GW, Umscheid CA, editors. Methods Guide for Medical Test Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jun. Chapter 9.

26.

Meta-Analysis of Test Performance When There Is a “Gold Standard”.

Trikalinos TA, Balion CM, Coleman CI, Griffith L, Santaguida PL, Vandermeer B, Fu R.

In: Chang SM, Matchar DB, Smetana GW, Umscheid CA, editors. Methods Guide for Medical Test Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jun. Chapter 8.

27.

Chapter 9: options for summarizing medical test performance in the absence of a "gold standard".

Trikalinos TA, Balion CM.

J Gen Intern Med. 2012 Jun;27 Suppl 1:S67-75. doi: 10.1007/s11606-012-2031-7.

28.

Chapter 8: meta-analysis of test performance when there is a "gold standard".

Trikalinos TA, Balion CM, Coleman CI, Griffith L, Santaguida PL, Vandermeer B, Fu R.

J Gen Intern Med. 2012 Jun;27 Suppl 1:S56-66. doi: 10.1007/s11606-012-2029-1.

29.

Feasibility of biological specimen collection for the Canadian longitudinal study on aging (CLSA) biorepository.

Balion CM, Raina PS, Wolfson C, Kirkland SA, Keys JL, Griffith LE, Pelletier A, Uniat J, McQueen MJ.

Can J Aging. 2009 Sep;28(3):261-74. doi: 10.1017/S0714980809990080.

PMID:
19860981
30.

The Canadian longitudinal study on aging (CLSA).

Raina PS, Wolfson C, Kirkland SA, Griffith LE, Oremus M, Patterson C, Tuokko H, Penning M, Balion CM, Hogan D, Wister A, Payette H, Shannon H, Brazil K.

Can J Aging. 2009 Sep;28(3):221-9. doi: 10.1017/S0714980809990055.

PMID:
19860977
31.

Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review.

Rodríguez-Capote K, Balion CM, Hill SA, Cleve R, Yang L, El Sharif A.

Clin Chem. 2009 Dec;55(12):2190-7. doi: 10.1373/clinchem.2009.128546. Epub 2009 Oct 1. Review.

32.

Utility of monitoring mycophenolic acid in solid organ transplant patients.

Oremus M, Zeidler J, Ensom MH, Matsuda-Abedini M, Balion C, Booker L, Archer C, Raina P.

Evid Rep Technol Assess (Full Rep). 2008 Feb;(164):1-131. Review.

33.

Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?

Balion CM, McKelvie RS, Reichert S, Santaguida P, Booker L, Worster A, Raina P, McQueen MJ, Hill S.

Clin Biochem. 2008 Mar;41(4-5):266-76. Epub 2007 Oct 16. Review.

PMID:
17991434
34.

Brain type carnosinase in dementia: a pilot study.

Balion CM, Benson C, Raina PS, Papaioannou A, Patterson C, Ismaila AS.

BMC Neurol. 2007 Nov 5;7:38.

35.

Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.

Balion CM, Santaguida P, McKelvie R, Hill SA, McQueen MJ, Worster A, Raina PS.

Clin Biochem. 2008 Mar;41(4-5):231-9. Epub 2007 Oct 16.

PMID:
17967418
36.

A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease.

Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R, Worster A, Booker L, Hill SA.

Clin Biochem. 2008 Mar;41(4-5):260-5. Epub 2007 Sep 25. Review.

PMID:
17949703
37.

Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care.

Hill SA, Balion CM, Santaguida P, McQueen MJ, Ismaila AS, Reichert SM, McKelvie R, Worster A, Raina PS.

Clin Biochem. 2008 Mar;41(4-5):240-9. Epub 2007 Sep 6. Review.

PMID:
17920053
38.

Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review.

Worster A, Balion CM, Hill SA, Santaguida P, Ismaila A, McKelvie R, Reichert SM, McQueen MJ, Booker L, Raina PS.

Clin Biochem. 2008 Mar;41(4-5):250-9. Epub 2007 Aug 24. Review.

PMID:
17915204
39.

Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.

Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P.

Evid Rep Technol Assess (Full Rep). 2006 Sep;(142):1-147. Review.

40.

Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review.

Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L, Hunt DL.

Clin Chem Lab Med. 2007;45(9):1180-5. Review. Erratum in: Clin Chem Lab Med. 2007;45(11):1570.

PMID:
17635074
41.

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L.

Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. Epub 2007 Jun 29. Review.

PMID:
17601626
42.
43.

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S; HOPE Study Investigators.

Circulation. 2006 Jul 18;114(3):201-8. Epub 2006 Jul 10.

PMID:
16831981
44.

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H.

Evid Rep Technol Assess (Summ). 2005 Aug;(128):1-11. Review. No abstract available.

45.

Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients.

Balion CM, Draisey TF, Thibert RJ.

Kidney Int. 1998 Feb;53(2):488-95.

46.

Evaluation of HemogloBind for removal of o-raffinose cross-linked hemoglobin (Hemolink) from serum.

Balion CM, Champagne PA, Ali AC.

Clin Chem. 1997 Sep;43(9):1796-7. No abstract available.

47.

Regulation of carnosine metabolism: the subcellular localization of carnosinase in liver.

Kalra J, Balion C, Massey KL, Laxdal VA.

Clin Biochem. 1988 Oct;21(5):315-8.

PMID:
3233742

Supplemental Content

Loading ...
Support Center